Fermentalg's 2026 Half-Year Results: Financial Stability and Strategic Growth

Fermentalg has reported stable half-year results for 2026. The company has focused on maintaining financial discipline while preparing for a new growth cycle. Sales of the DHA ΩRIGINS™ range have grown, and production of the new EPA/DHA range has commenced. The company also received initial orders for its natural blue colorant, Galdieria Blue, expecting volume deliveries by year-end.

Revenue in H1 2026 was €7.4 million, close to the previous year's €7.6 million, with a notable improvement in gross margin from 16% to 23%. This growth offset a decline in sales to the aquaculture market. Operating costs were reduced by 6% outside R&D, reflecting stringent financial management.

Fermentalg's financial resources were bolstered by a successful €10.4 million capital increase, enhancing its cash position to €10.8 million, with minimal financial debt. The company anticipates a growth acceleration from Q4 2026.